Arizona Oncology - The US Oncology Network

Arizona Oncology Promotes Awareness of Sarcoma

7/02/2011

Each year approximately 12,900 Americans, both children and adults, are diagnosed with sarcoma. July is set aside nationally to raise awareness for this cancer that develops in the connective tissue of the body such as fat, blood vessels, nerves, bones, muscles, deep skin tissues, and cartilage.

This rare cancer is divided into two main groups, bone tumors and soft tissue sarcomas. Most diagnoses are soft tissue; about 10,500 cases are diagnosed each year, accounting for less than 1 percent of all cancers. It is most common in young adults, age 15-35. Symptoms for this rare cancer may be caused by the cancer itself or as a result of other problems and include:

  • A new lump or lump that is growing anywhere on your body
  • Rarely, the lump may be painful or swollen

 Currently the cause for soft tissue sarcoma is unknown, but several risk factorsthat increase a person’s chance of getting the disease have been identified:

 

  • Radiation exposure: Accounting for less than 5 percent of sarcomas, radiation given to treat other cancers, like breast cancer or lymphoma, may lead to the development of sarcomas. The average time between radiation exposure and diagnosis of a sarcoma is about 10 years.
  • Genetic syndromes: Certain inherited conditions such as neurofibromatosis, Gardner syndrome, Li-Fraumeni syndrome, retinoblastoma, Werner syndrome, nevoid basal cell carcinoma syndrome and Tuberous sclerosis increase a person's risk of developing soft tissue sarcomas.
  • Damaged lymph system

The American Cancer Societysuggests individualswith a strong family history of sarcomas, or other cancers occurring at a young age, discuss the benefits and disadvantages of genetic testing with their doctor. For those with no family history of sarcoma or other sarcoma risk factors the best approach to early detection is to notify their health care professional of any unexplained lumps, growths or other symptoms right away.

Arizona Oncologyplays a major role in helping patients in Arizona and their families win the battle against sarcoma by providing easy access to a full range of advanced cancer care services in a setting that allows patients to remain close to their homes and their support networks of family and friends.  As a member of the US Oncology network, we can quickly bring the latest advances in therapies, research and technology to where patients live. As a result, patients access the best possible treatment with the least amount of disruption to their daily lives.

 

-end-

ABOUT ARIZONA ONCOLOGY

Arizona Oncology is the largest group of medical professionals in Arizona devoted exclusively to cancer care. With 48 practicing physicians, we serve patients at more than 24 locations throughout Arizona, including Cottonwood, Deer Valley, Flagstaff, Green Valley, Marana, Nogales, Oro Valley, Phoenix, Prescott Valley, Safford, Scottsdale, Sedona, Sierra Vista and Tucson. We are proud to provide comprehensive, compassionate, cancer care in a patient-focused, cost effective, community-based setting. Arizona Oncology provides patients with access to the latest treatments, state-of-the-art technology and access to cutting edge nationwide research and clinical trials. We believe it is beneficial when these therapies are provided in a community setting, close to patients' home and your support system. Our physicians are supported by talented clinical staff members who are sensitive to the needs of cancer patients and their caregivers. For more information, please visit www.ArizonaOncology.com.

Arizona Oncology is united in healing with US Oncology, a division of McKesson Corporationand a leading integrated oncology company uniting one of the nation’s largest community-based cancer treatment and research networks. As an affiliate of the United Network of US Oncology, Arizona Oncology is united with more than 1,100 physicians and 10,000 cancer professionals nationwide. Through the US Oncology Research Network, Arizona Oncology participates in clinical trials and has helped to develop 43 FDA approved cancer therapies.For more information, visit www.usoncology.com.